18 May 2013
Keywords: antisoma, r1549, trial, results, likely, sooner, uk
Article | 28 July 2003
UK biotechnology firm Antisoma has announced a revised projection for the completion date for its pivotal Phase III SMART study ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 July 2003
17 May 2013
© 2013 thepharmaletter.com